AstraZeneca and Merck & Co’s partnership to develop ovarian cancer drug Lynparza has got off to a good start after the FDA approved its use in a wider group of women. The drug has been approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results